Trial Profile
Clinical Trials Insight: 700051452
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 01 Dec 2009
Price :
$35
*
At a glance
- Drugs Semapimod (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- Sponsors Cytokine PharmaSciences
- 01 Dec 2009 New trial record.